Oral bisphosphonates may lower jaw necrosis risk
January 3, 2008 — NEW YORK (Reuters Health) - A report in the Journal of the American Dental Association clarifies the risk of jaw osteonecrosis associated with bisphosphonates, which are used to prevent or slow the progression of osteoporosis.
Select news items provided by Reuters Health